Example: Heart Attack

Search clinical trials for: Clofarabine

Total 170 results

NCT01842672

Unknown status

Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia

Conditions: Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Lymphoblastic Lymphoma; Diffuse Large B-cell Lymphoma; Burkitt Lymphoma/Leukemia
NCT01169012

Completed

PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias

Conditions: Myelodysplastic Syndrome; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelomonocytic Leukemia
NCT02888301

Terminated

18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions

Conditions: Malignant Neoplasm
NCT02425904

Active, not recruiting

Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders

Conditions: Langerhans Cell Histiocytosis
NCT01960387

Terminated

Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia
NCT00924443

Completed

A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable

Conditions: Acute Myeloid Leukemia
NCT00334074

Completed

Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS

Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndromes; Chronic Myelogenous Leukemia
NCT02544789

Completed

Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

Conditions: Acute Lymphoblastic Leukemia
NCT02686593

Completed

Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML

Conditions: Acute Myeloid Leukemia
NCT00852163

Completed

Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

Conditions: Leukemia; Myelodysplastic Syndrome
NCT00422032

Completed

2 Arm Study of Clofarabine IV in MDS Patients

Conditions: Myelodysplastic Syndrome; Leukemia
NCT01422603

Completed

Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)

Conditions: Acute Myeloid Leukaemia; Myelodysplasia
NCT00529360

Completed

Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL

Conditions: Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia
NCT00800566

Withdrawn

Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)

Conditions: Leukemia; Chronic Lymphocytic Leukemia
NCT02211755

Recruiting

Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

Conditions: Neoplasms; Myelodysplastic Syndromes; Lymphomas
NCT00373529

Completed

A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)

Conditions: Acute Myelogenous Leukemia; Acute Myeloid Leukemia
NCT00644189

Active, not recruiting

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Conditions: Follicular Lymphoma; Marginal Zone Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma; Lymphoplasmacytic Lymphoma; Low Grade B-cell Lymphoma, Not Otherwise Specified; Diffuse Large B-cell Lymphoma; Peripheral T-cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large-cell Lymphoma
NCT00708721

Terminated

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Conditions: Cancer; Chronic Myelomonocytic Leukemia
NCT00700011

Terminated

Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)

Conditions: Myelodysplastic Syndromes
NCT01534702

Unknown status

Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML

Conditions: Acute Myeloid Leukemia
NCT01065545

Withdrawn

The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia
NCT01444742

Completed

Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)

Conditions: Leukemia; Myeloproliferative Diseases
NCT00724009

Completed

Clofarabine Bone Marrow Cytoreduction

Conditions: Leukemia
NCT01063257

Completed

Clofarabine in High Risk Myelodysplastic Syndrome (MDS)

Conditions: Myelodysplastic Syndrome
NCT01796405

Withdrawn

Clofarabine for Langerhans in Pedi

Conditions: Langerhans Cell Histiocytosis